BREAKFAST DEALS: Symbion medicine

Symbion’s float gives a hand to the local IPO market, while Nine plays hard to keep things cricket.

Pharmaceutical wholesaler Symbion is heading for the ASX after its Swiss owners sold the business to New Zealand’s EBOS Group. Nine Entertainment is having to stretch itself to keep the cricket broadcasting rights. Elsewhere, Optus has two big private equity players fishing for its Australian satellite business and Australand Property Group apparently has someone hunting part of its residential book.

EBOS Group, Symbion

It’s always hard for Australians to accept a hand from Kiwis. But the local float market has little choice.


SMS Code Sent…

Hi {{ user.FirstName }}

Looks like you've already taken a free trial

We have sent you a code via SMS to {{user.DayPhone}}

please enter this code below to activate your membership

If you didn't receive SMS code please

Looks you are already a member. Please enter your password to proceed

Verify your mobile number to unlock a FREE trial

Please sign up for full access

Updating information

Please wait ...

Related Articles